-
Product Insights
NewLikelihood of Approval Analysis for Dyskinesia
Overview How likely is it that the drugs in Dyskinesia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dyskinesia Overview Dyskinesia refers to the involuntary nature of muscular movements or the...
-
Product Insights
NewLikelihood of Approval Analysis for Dystonia
Overview How likely is it that the drugs in Dystonia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dystonia Overview Dystonia is a neurological hyperkinetic movement disorder in which sustained or...
-
Product Insights
NewLikelihood of Approval Analysis for Upper Limb Muscle Spasticity
Overview How likely is it that the drugs in Upper Limb Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upper Limb Muscle Spasticity Overview Spasms or spasticity is a...
-
Product Insights
NewLikelihood of Approval Analysis for Muscle Spasticity
Overview How likely is it that the drugs in Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Muscle Spasticity Overview Muscle spasticity is a condition that causes muscles to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rimtuzalcap in Movement Disorders
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Rimtuzalcap in Movement Disorders Drug Details: Rimtuzalcap (CAD-1883) is under development for the treatment of...
-
Analyst Opinions
NewCocktail Culture – Industry Insights, Consumer Drivers, Brand Challenges and Innovation Landscape
Cocktail Culture Industry Report Overview The cocktail culture is a historic trend that has undergone several movements over the decades. In the 21st century, it has benefited from the craft alcohol movement and demand for premium experiences.  In 2024, cocktail culture has been influenced by relatively recent developments such as the craft craze, COVID's elevation of home-based indulgence and entertaining, increased RTD product diversity and sophistication, and the emergence of a more experiential-focused Gen Z consumer base. The ‘Cocktail Culture...
-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Product Insights
NewLikelihood of Approval Analysis for Leber Congenital Amaurosis (LCA)
Overview How likely is it that the drugs in Leber Congenital Amaurosis (LCA) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leber Congenital Amaurosis (LCA) Overview Leber congenital amaurosis (LCA) is...
-
Product Insights
NewLikelihood of Approval Analysis for Partial Seizure
Overview How likely is it that the drugs in Partial Seizure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Partial Seizure Overview Focal onset seizures, or partial seizures, are prevalent neurological...
-
Product Insights
NewLikelihood of Approval Analysis for Gastroparesis
Overview How likely is it that the drugs in Gastroparesis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastroparesis Overview Gastroparesis, also called delayed gastric emptying, is a disorder that slows...